サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/04 | 2,110 | 2,116 | 1,995 | 2,039 | -120 | -5.6% | 1,752,800 |
| 2022/03/03 | 2,196 | 2,220 | 2,114 | 2,159 | -19 | -0.9% | 2,038,200 |
| 2022/03/02 | 2,068 | 2,200 | 1,927 | 2,178 | +101 | +4.9% | 2,776,600 |
| 2022/03/01 | 1,899 | 2,126 | 1,874 | 2,077 | +214 | +11.5% | 3,337,700 |
| 2022/02/28 | 1,622 | 1,863 | 1,616 | 1,863 | +216 | +13.1% | 2,338,500 |
| 2022/02/25 | 1,601 | 1,666 | 1,578 | 1,647 | +86 | +5.5% | 1,222,600 |
| 2022/02/24 | 1,648 | 1,663 | 1,545 | 1,561 | -84 | -5.1% | 1,716,900 |
| 2022/02/22 | 1,510 | 1,670 | 1,510 | 1,645 | +87 | +5.6% | 2,793,400 |
| 2022/02/21 | 1,381 | 1,566 | 1,351 | 1,558 | +129 | +9% | 1,997,700 |
| 2022/02/18 | 1,402 | 1,499 | 1,386 | 1,429 | -44 | -3% | 1,627,300 |
| 2022/02/17 | 1,600 | 1,602 | 1,411 | 1,473 | -173 | -10.5% | 2,326,900 |
| 2022/02/16 | 1,700 | 1,758 | 1,560 | 1,646 | -39 | -2.3% | 6,966,400 |
| 2022/02/15 | 1,685 | 1,685 | 1,685 | 1,685 | +300 | +21.7% | 213,700 |
| 2022/02/14 | 1,385 | 1,385 | 1,385 | 1,385 | +300 | +27.6% | 78,400 |
| 2022/02/10 | 1,101 | 1,132 | 1,082 | 1,085 | -13 | -1.2% | 369,500 |
| 2022/02/09 | 1,117 | 1,122 | 1,079 | 1,098 | +4 | +0.4% | 205,700 |
| 2022/02/08 | 1,100 | 1,117 | 1,089 | 1,094 | -7 | -0.6% | 186,400 |
| 2022/02/07 | 1,097 | 1,118 | 1,087 | 1,101 | +4 | +0.4% | 217,600 |
| 2022/02/04 | 1,120 | 1,133 | 1,077 | 1,097 | -12 | -1.1% | 368,900 |
| 2022/02/03 | 1,100 | 1,111 | 1,084 | 1,109 | -7 | -0.6% | 315,500 |
| 2022/02/02 | 1,094 | 1,127 | 1,090 | 1,116 | +45 | +4.2% | 265,400 |
| 2022/02/01 | 1,081 | 1,103 | 1,056 | 1,071 | -12 | -1.1% | 262,800 |
| 2022/01/31 | 1,036 | 1,092 | 1,036 | 1,083 | +43 | +4.1% | 329,300 |
| 2022/01/28 | 1,080 | 1,097 | 1,017 | 1,040 | -29 | -2.7% | 312,200 |
| 2022/01/27 | 1,124 | 1,140 | 1,057 | 1,069 | -27 | -2.5% | 340,600 |
| 2022/01/26 | 1,052 | 1,115 | 1,052 | 1,096 | +41 | +3.9% | 275,800 |
| 2022/01/25 | 1,139 | 1,145 | 1,047 | 1,055 | -56 | -5% | 463,300 |
| 2022/01/24 | 1,095 | 1,120 | 1,075 | 1,111 | -10 | -0.9% | 299,100 |
| 2022/01/21 | 1,168 | 1,179 | 1,115 | 1,121 | -71 | -6% | 388,600 |
| 2022/01/20 | 1,193 | 1,223 | 1,167 | 1,192 | -16 | -1.3% | 340,800 |
| 2022/01/19 | 1,250 | 1,253 | 1,199 | 1,208 | -45 | -3.6% | 366,400 |
| 2022/01/18 | 1,255 | 1,295 | 1,242 | 1,253 | +3 | +0.2% | 338,800 |
| 2022/01/17 | 1,300 | 1,314 | 1,241 | 1,250 | -50 | -3.8% | 390,000 |
| 2022/01/14 | 1,250 | 1,321 | 1,242 | 1,300 | +50 | +4% | 671,900 |
| 2022/01/13 | 1,250 | 1,273 | 1,239 | 1,250 | -43 | -3.3% | 380,800 |
| 2022/01/12 | 1,303 | 1,325 | 1,255 | 1,293 | -11 | -0.8% | 855,200 |
| 2022/01/11 | 1,171 | 1,325 | 1,160 | 1,304 | +125 | +10.6% | 1,564,800 |
| 2022/01/07 | 1,082 | 1,223 | 1,057 | 1,179 | +119 | +11.2% | 1,072,700 |
| 2022/01/06 | 1,055 | 1,088 | 1,053 | 1,060 | -16 | -1.5% | 294,400 |
| 2022/01/05 | 1,050 | 1,098 | 1,028 | 1,076 | +22 | +2.1% | 365,900 |
| 2022/01/04 | 1,029 | 1,059 | 1,005 | 1,054 | +47 | +4.7% | 544,500 |
| 2021/12/30 | 1,016 | 1,017 | 996 | 1,007 | -9 | -0.9% | 320,800 |
| 2021/12/29 | 1,019 | 1,038 | 990 | 1,016 | +13 | +1.3% | 472,600 |
| 2021/12/28 | 1,050 | 1,061 | 998 | 1,003 | -39 | -3.7% | 786,800 |
| 2021/12/27 | 1,108 | 1,108 | 1,037 | 1,042 | -83 | -7.4% | 711,500 |
| 2021/12/24 | 1,131 | 1,153 | 1,120 | 1,125 | -8 | -0.7% | 362,700 |
| 2021/12/23 | 1,165 | 1,172 | 1,131 | 1,133 | -40 | -3.4% | 385,700 |
| 2021/12/22 | 1,140 | 1,183 | 1,131 | 1,173 | +15 | +1.3% | 583,100 |
| 2021/12/21 | 1,214 | 1,223 | 1,138 | 1,158 | -45 | -3.7% | 844,500 |
| 2021/12/20 | 1,115 | 1,221 | 1,111 | 1,203 | +71 | +6.3% | 1,846,000 |
851～
900
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
